A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters
- PMID: 1648153
- DOI: 10.1016/0165-0270(91)90142-m
A system, using neural cell lines, to characterize HSV-1 vectors containing genes which affect neuronal physiology, or neuronal promoters
Abstract
Among the potential uses of defective herpes simplex virus (HSV-1) vectors are to study neuronal physiology, neuronal gene regulation, and to perform gene therapy of neuronal diseases. The prototype HSV-1 vector, pHSVlac, stably expresses Escherichia coli beta-galactosidase from the HSV-1 immediate early (IE) 4/5 promoter in cultured rat peripheral and CNS neurons, and in neurons in the adult rat brain. The LacZ gene and the IE 4/5 promoter in pHSVlac can be replaced with genes which affect neuronal physiology or cellular promoters, respectively. A system is required to characterize these HSV-1 vectors; cultured neurons, a mixture of different kinds of neurons and glia, cannot be used. In contrast, neural cell lines represent a homogenous population of neural cells available in virtually unlimited quantities. A system, using neural cell lines, to characterize HSV-1 vectors carrying other genes or promoters is now reported: First, 4 assays are described to detect HSV-1 vector DNA, RNA transcribed from the vector, and to quantitate beta-galactosidase expression. Second, 8 cell lines derived from rodents, primates, and humans were infected with pHSVlac virus and shown to express beta-galactosidase. The cell lines tested included adrenergic and cholinergic mouse neuroblastoma cells, rat pheochromocytoma cells, rodent pituicytes, and human neuroblastoma cells. Infection of these cell lines should prove useful for characterizing HSV-1 vectors with molecular and biochemical assays. Third, differentiated rat pheochromocytoma and mouse neuroblastoma cells, which resemble neurons, were infected with pHSVlac virus and shown to stably express beta-galactosidase. Infection of these cells should be useful for determining the effect of various HSV-1 vectors on neuronal physiology. Thus, HSV-1 vectors containing various genes or promoters can be characterized using the system described in this study.
Similar articles
-
Influence of the helper virus on expression of beta-galactosidase from a defective HSV-1 vector, pHSVlac.J Virol Methods. 1991 Feb-Mar;31(2-3):229-38. doi: 10.1016/0166-0934(91)90161-r. J Virol Methods. 1991. PMID: 1650784
-
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.Biotechniques. 1996 Mar;20(3):460-9. doi: 10.2144/19962003460. Biotechniques. 1996. PMID: 8679207
-
An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.Proc Natl Acad Sci U S A. 1990 Nov;87(22):8950-4. doi: 10.1073/pnas.87.22.8950. Proc Natl Acad Sci U S A. 1990. PMID: 2174168 Free PMC article.
-
Gene transfer to brain using herpes simplex virus vectors.Ann Neurol. 1994;35 Suppl:S28-34. doi: 10.1002/ana.410350710. Ann Neurol. 1994. PMID: 8185293 Review.
-
Herpesviruses: expression of genes in postmitotic brain cells.Curr Opin Genet Dev. 1993 Feb;3(1):81-5. doi: 10.1016/s0959-437x(05)80345-4. Curr Opin Genet Dev. 1993. PMID: 8384036 Review.
Cited by
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21. doi: 10.1097/00000658-199909000-00004. Ann Surg. 1999. PMID: 10493478 Free PMC article.
-
Improvement of HSV-1 based amplicon vectors for a safe and long-lasting gene therapy in non-replicating cells.Mol Ther Methods Clin Dev. 2021 Mar 29;21:399-412. doi: 10.1016/j.omtm.2021.03.020. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33869657 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources